Northwestern study tests drug against Parkinson's disease

(Northwestern University) Northwestern University Feinberg School of Medicine was awarded a grant from the National Institutes of Health to conduct a $16 million phase III national study of the safety and efficacy of the drug isradipine as a potential neuroprotective agent in Parkinson's disease. This is the only phase III Parkinson's neuroprotective study currently funded by the National Institute of Neurological Disorders and Stroke at NIH.
Source: EurekAlert! - Biology - Category: Biology Source Type: news